Skip to content
Agentic OS
Menu

Intelligence / Healthtech / PMA Approvals / Rayner Intraocular Lenses , LTD.

Approvalsdevice change approved (PMA)24 Sept 2026

Rayner Intraocular Lenses , LTD.

24 Sept 2026: Device change approved (PMA) · RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615X. Recorded in the openFDA device PMA data.

View the source record

Decided
24 Sept 2026
Device
RayOne Galaxy; Model RAO605G, RayOne Galaxy Toric; Model RAO615X
Specialty
Ophthalmic
Type
Supplement (Panel Track)
Reason
Labeling Change - Indications/instructions/shelf life/tradename
Reference
P060011 S045
Location
Hove, E. Sussex
What this signal means

A PMA approval is a high-risk device launch: reimbursement, distribution, clinical training and sales hires follow.

  1. Cardiovascular leads with 53 of 120, then Pathology (15).
  2. 35 added in the 30 days to 18 Nov 2026.
Reach them with AOS

Find the decision makers at Rayner Intraocular Lenses , LTD.

AOS maps the buying committee, finds verified work emails and drafts outreach that cites this approvals signal, for your approval.

Start free

More in Ophthalmic

PMA Approvals

See all

Source: openFDA device PMA data, data to 18 Nov 2026. Class III devices approved by FDA: original approvals and supplements that change the device (180-day, panel-track and special tracks). 30-day manufacturing notices are left out. AOS shows what the public record says; it does not verify or endorse the company.